Village Super Market Inc. Class A Common Stock (VLGEA)
StalwartFairStock Score: 65/100 — STEADY
Key Financials
| Current Price | $45.17 |
| Market Cap | $635M |
| P/E Ratio | 12.31 |
| ROE | 10.93% |
| Dividend Yield | 2.5% |
| Sector | Consumer Defensive |
Strengths
- Generates $43 million in annual free cash flow (6.8% yield on market cap)
- Strong Piotroski F-Score of 8/9 indicating robust financial health across profitability, leverage, and efficiency metrics
- Solid return on equity of 11.4% above cost of capital
- Attractive 2.3% dividend yield providing steady income returns
AI Analysis
Village Super Market Inc. Class A Common Stock is a micro-cap consumer defensive company valued at $635 million. Revenue stands at $2.4 billion. From a quality standpoint, Village shows near-perfect Piotroski F-Score of 8/9 indicating exceptional financial health and Altman Z-Score of 2.1 in the grey zone. On valuation, the stock is attractively valued at 11.3x earnings, with a modest 22% margin of safety vs Graham Number. Growth dynamics show revenue growing at 6.9% and profit growth of 5.8%. The 2.3% dividend yield adds an income component for patient holders. Our composite FairStock Score of 65/100 reflects above-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $43 million in annual free cash flow (6.8% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the consumer defensive space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer